Supplementary Figures S1-S18 from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Figures S1-S18 from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 ActivationKeywords
This publication has 0 references indexed in Scilit: